LRI Investments’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10
Closed -$165 1319
2025
Q2
$165 Hold
10
﹤0.01% 1247
2025
Q1
$182 Hold
10
﹤0.01% 1190
2024
Q4
$371 Hold
10
﹤0.01% 1132
2024
Q3
$360 Hold
10
﹤0.01% 1126
2024
Q2
$821 Hold
10
﹤0.01% 1106
2024
Q1
$1.45K Buy
+10
New +$844 ﹤0.01% 776

Other funds holding CDLX

LRI Investments's CDLX Position: Q3 2025 in Review

LRI Investments sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 10 shares — an estimated $165 sold.

LRI Investments first reported a position in CDLX in Q1 2024 and held it in 6 quarters. The position peaked at $1.45K in Q1 2024. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

  • LRI Investments reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
  • LRI Investments sold 10 Cardlytics shares in Q3 2025, an estimated $165.
  • LRI Investments first reported a position in Cardlytics in Q1 2024 and held it in 6 quarters.
  • LRI Investments's Cardlytics position peaked at $1.45K in Q1 2024.
  • 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on LRI Investments's 13F filing for Q3 2025, filed 3 Nov 2025.